Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G9AP
|
||||
Former ID |
DIB005449
|
||||
Drug Name |
E-2011
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Terminated | [545345] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1(=O)N(c2cc3sc(nc3cc2)[C@@H](O)CCC#N)C[C@@H](O1)COC
|
||||
CAS Number |
CAS 150366-18-0
|
||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] A | Target Info | Modulator | [534616] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.